Assessment of Bronchial Asthma Among Patients Attending Sohag University Hospital

Bronchial Asthma Clinical Trial

Official title:

Assessment of Bronchial Asthma Among Patients Attending Sohag University Hospital

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06141161
• Other study ID #: Soh-Med-23-10-015MS
• Status: Recruiting
• Start date: November 1, 2023
• Est. completion date: December 30, 2024

Study information

• Verified date: November 2023
• Source: Sohag University
• Contact: Doha M ismail, Resident
• Phone: 01128028508
• Email: dohaismail[@]med.sohag.edu.eg
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Asthma is a significant public health threat, affecting more than 300 million individuals globally. Asthma is classified as a non-communicable disease and leads to reduced quality of life, poor physical functioning and reduced emotional well-being. The impact of this disease can be widespread and extends beyond the person living with the disease, affecting the lives of their family members, carers, communities and the health care system (1). Asthma is a variable chronic respiratory condition. It is characterized by symptoms of wheeze, cough, chest tightness, dyspnea and backed by variable airflow limitation, airway inflammation and airway hyper-responsiveness (AHR). The severity of asthma varies considerably, both between individuals and within individuals over time. Some people may have intermittent asthma and others may experience severe, potentially life-threatening disease (2, 3,4).

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 200
• Est. completion date: December 30, 2024
• Est. primary completion date: December 30, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• bronchial asthma patients aged more than 18 years, both sexes are included

Exclusion Criteria:

• children ,patients who are unable to do spiromerty or contrindecated

Related Conditions & MeSH terms

• Asthma
• Bronchial Asthma

Intervention

Drug:
• corticosteroids
inhailed or oral corticosteroids

Locations

Country	Name	City	State
Egypt	Sohag University hospitals	Sohag

Sponsors (1)

Lead Sponsor	Collaborator
Sohag University

Country where clinical trial is conducted

Egypt, 

References & Publications (4)

Al-Moamary MS, Alhaider SA, Al-Hajjaj MS, Al-Ghobain MO, Idrees MM, Zeitouni MO, Al-Harbi AS, Al Dabbagh MM, Al-Matar H, Alorainy HS. The Saudi initiative for asthma - 2012 update: Guidelines for the diagnosis and management of asthma in adults and children. Ann Thorac Med. 2012 Oct;7(4):175-204. doi: 10.4103/1817-1737.102166. — View Citation

Braido F, Canonica GW. Worldwide differences on the concept of control of asthma. Ther Adv Respir Dis. 2008 Feb;2(1):3-5. doi: 10.1177/1753465807087091. — View Citation

Dashash NA, Mukhtar SH. Prescribing for asthmatic children in primary care. Are we following guidelines? Saudi Med J. 2003 May;24(5):507-11. — View Citation

National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol. 2007 Nov;120(5 Suppl):S94-138. doi: 10.1016/j.jaci.2007.09.043. Erratum In: J Allergy Clin Immunol. 2008 Jun;121(6):1330. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	percent of controlled bronchial asthma patients	to detect percent of controlled patients	12 months